Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 49 out of 100. Caregiving

Topic: Risk, prevention and care in population studies

Plain-language summary

Vascular contributions to cognitive impairment and dementia (VCID) are common and may be the most preventable cause of clinically significant cognitive decline. However, an estimate of the prevalence and incidence of VCID in the United States is lacking. In this scientific statement, we reviewed studies on the incidence and prevalence of VCID, defined as patients diagnosed with vascular dementia, evidence of vascular dementia in epidemiological studies, neuropathological evidence of cerebrovascular contributions to dementia, and neuroimaging evidence of covert (clinically silent) cerebrovascular disease. We found variability in estimates of vascular dementia, with a higher prevalence in prospective epidemiological and autopsy-based studies than studies of physician diagnoses. There were many more studies of vascular contributions to dementia than to mild cognitive impairment. Epidemiological studies suggest that in the 2020 US population >65 years of age, 2.7 million individuals were living with vascular dementia or mixed dementia with a vascular contribution, whereas health care billing data suggest that 809 000 people were diagnosed with vascular dementia. In 2020, as many as 603 000 new individuals developed new vascular dementia or mixed vascular dementia according to epidemiological studies, whereas there were 102 000 new cases according to health care billing data. In addition, we estimate that in 2020 there were 11.3 million people with covert brain infarcts, 11.1 million with high volumes of white matter hyperintensity, and 19.9 million with cerebral microbleeds potentially detectable by magnetic resonance imaging, contributing to VCID. These covert cerebrovascular lesions may be preventable with appropriate risk factor modification. Indeed, we estimate that eliminating cerebrovascular disease from the population would prevent 27% to 33% of dementia cases, resulting in 1.5 to 1.8 million fewer people with dementia in 2020. Population health approaches to reduce VCID would benefit millions of Americans.

What this study adds

Evidence grade: Low

This scientific statement reports that vascular contributions to cognitive impairment and dementia are common and may be the most preventable cause of clinically significant cognitive decline. It found variability in estimates of vascular dementia, with higher prevalence in prospective epidemiological and autopsy-based studies than in physician diagnoses.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Smith, E. E., Aparicio, H. J., Gottesman, R. F., Goyal, M. S., Greenberg, S. M., Schneider, J. A., et al. (2025). Vascular Contributions to Cognitive Impairment and Dementia in the United States: Prevalence and Incidence: A Scientific Statement From the American Heart Association. Stroke. https://doi.org/10.1161/str.0000000000000494

Vancouver

Smith EE, Aparicio HJ, Gottesman RF, Goyal MS, Greenberg SM, Schneider JA, et al. Vascular Contributions to Cognitive Impairment and Dementia in the United States: Prevalence and Incidence: A Scientific Statement From the American Heart Association. Stroke. 2025. doi:10.1161/str.0000000000000494. PMID: 40820756.

BibTeX

@article{smith2025-40820756,
  author  = {Smith, Eric Edward and Aparicio, Hugo Javier and Gottesman, Rebecca F. and Goyal, Manu S. and Greenberg, Steven Mark and Schneider, Julie A. and Sorond, Farzaneh A. and Wright, Clinton B.},
  title   = {{Vascular Contributions to Cognitive Impairment and Dementia in the United States: Prevalence and Incidence: A Scientific Statement From the American Heart Association}},
  journal = {Stroke},
  year    = {2025},
  doi     = {10.1161/str.0000000000000494},
  pmid    = {40820756},
  url     = {https://doi.org/10.1161/str.0000000000000494}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This scientific statement reports that vascular contributions to cognitive impairment and dementia are common and may be the most preventable cause of clinically significant cognitive decline. It found variability in estimates of vascular dementia, with higher prevalence in prospective epidemiological and autopsy-based studies than in physician diagnoses.

Study details

How this study scored 49/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 5 of 6; Cited by studies here 1 of 6; Still being cited 3 of 4; Senior author's track record 3 of 4; Institution's track record left out, no data; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 48 of the 97 points it could be judged on, which is 49 of 100. Total 49 of 100.48 of the 97 points we could judge = 49 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 48 of the 97 points we could judge it on, which is 49 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Stroke)
Journal's citation record 3 / 4 Stroke: journal h-index 455 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 52 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 17.3 citations a year over 3 year(s) since 2025
Impact for its field and year 5 / 6 Cited 32.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 3 / 4 Cited 52 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Clinton B. Wright: h-index 67 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40820756)
Free to read 2 / 2 Free to read
Points 48 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 48 of the 97 points we could judge it on is 49 out of 100.
Total 49 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 37.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Caregiving from nearby years

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Caregiving

See all studies in Caregiving →